Business Description
Alar Pharmaceuticals Inc
ISIN : TW0006785009
Share Class Description:
ROCO:6785: Ordinary SharesDescription
Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5717.9 | |||||
| Equity-to-Asset | 0.98 | |||||
| Interest Coverage | 11346.18 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 110.9 | |||||
| Beneish M-Score | 260.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 781.7 | |||||
| 3-Year Book Growth Rate | 14.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.17 | |||||
| 9-Day RSI | 59.27 | |||||
| 14-Day RSI | 51.42 | |||||
| 6-1 Month Momentum % | -41.92 | |||||
| 12-1 Month Momentum % | -13.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 45.14 | |||||
| Quick Ratio | 45.14 | |||||
| Cash Ratio | 44.92 | |||||
| Days Sales Outstanding | 0.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.94 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| Forward Dividend Yield % | 0.94 | |||||
| 5-Year Yield-on-Cost % | 0.94 | |||||
| Shareholder Yield % | -15.51 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.57 | |||||
| Operating Margin % | 81.34 | |||||
| Net Margin % | 84.49 | |||||
| FCF Margin % | 45.91 | |||||
| ROE % | 22.46 | |||||
| ROA % | 21.36 | |||||
| ROIC % | 345.82 | |||||
| ROC (Joel Greenblatt) % | 3236.55 | |||||
| ROCE % | 23.56 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.64 | |||||
| Forward PE Ratio | 409.46 | |||||
| PE Ratio without NRI | 22.64 | |||||
| PS Ratio | 19.27 | |||||
| PB Ratio | 4.34 | |||||
| Price-to-Tangible-Book | 4.33 | |||||
| Price-to-Free-Cash-Flow | 39.82 | |||||
| Price-to-Operating-Cash-Flow | 39.41 | |||||
| EV-to-EBIT | 19.61 | |||||
| EV-to-EBITDA | 19.45 | |||||
| EV-to-Revenue | 17.43 | |||||
| EV-to-FCF | 35.5 | |||||
| Price-to-Graham-Number | 2.09 | |||||
| Price-to-Net-Current-Asset-Value | 4.49 | |||||
| Price-to-Net-Cash | 4.51 | |||||
| Earnings Yield (Greenblatt) % | 5.1 | |||||
| FCF Yield % | 2.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alar Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 474.289 | ||
| EPS (TTM) (NT$) | 7.068 | ||
| Beta | 0.79 | ||
| Volatility % | 88.02 | ||
| 14-Day RSI | 51.42 | ||
| 14-Day ATR (NT$) | 6.423565 | ||
| 20-Day SMA (NT$) | 154.95 | ||
| 12-1 Month Momentum % | -13.78 | ||
| 52-Week Range (NT$) | 143 - 465 | ||
| Shares Outstanding (Mil) | 66.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alar Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alar Pharmaceuticals Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alar Pharmaceuticals Inc Frequently Asked Questions
What is Alar Pharmaceuticals Inc(ROCO:6785)'s stock price today?
The current price of ROCO:6785 is NT$160.00. The 52 week high of ROCO:6785 is NT$465.00 and 52 week low is NT$143.00.
When is next earnings date of Alar Pharmaceuticals Inc(ROCO:6785)?
The next earnings date of Alar Pharmaceuticals Inc(ROCO:6785) is .
Does Alar Pharmaceuticals Inc(ROCO:6785) pay dividends? If so, how much?
The Dividend Yield %  of Alar Pharmaceuticals Inc(ROCO:6785) is 0.94% (As of Today), Highest Dividend Payout Ratio of Alar Pharmaceuticals Inc(ROCO:6785) was 0.21. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Alar Pharmaceuticals Inc(ROCO:6785) is 0.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers